RGEN: Robust growth, strategic acquisitions, and tech innovation drive a positive outlook for margins and revenue
Strong organic growth and upgraded guidance were driven by standout performance in protein and analytics, while strategic acquisitions like BioLife Solutions are set to diversify and accelerate growth. Technology adoption, especially in PAT and AI, and regional expansion in China support a positive…